- Home
- TCI vs LYEL Comparison
TCI vs LYEL Comparison
Compare TCI & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCI
- LYEL
- Stock Information
- Founded
- TCI 1983
- LYEL 2018
- Country
- TCI United States
- LYEL United States
- Employees
- TCI N/A
- LYEL N/A
- Industry
- TCI Real Estate
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- TCI Finance
- LYEL Health Care
- Exchange
- TCI Nasdaq
- LYEL Nasdaq
- Market Cap
- TCI 239.1M
- LYEL 207.7M
- IPO Year
- TCI N/A
- LYEL 2021
- Fundamental
- Price
- TCI $39.33
- LYEL $0.44
- Analyst Decision
- TCI
- LYEL Sell
- Analyst Count
- TCI 0
- LYEL 2
- Target Price
- TCI N/A
- LYEL $1.00
- AVG Volume (30 Days)
- TCI 3.7K
- LYEL 627.4K
- Earning Date
- TCI 05-08-2025
- LYEL 05-13-2025
- Dividend Yield
- TCI N/A
- LYEL N/A
- EPS Growth
- TCI 59.61
- LYEL N/A
- EPS
- TCI 0.92
- LYEL N/A
- Revenue
- TCI $47,452,000.00
- LYEL $65,000.00
- Revenue This Year
- TCI N/A
- LYEL N/A
- Revenue Next Year
- TCI N/A
- LYEL N/A
- P/E Ratio
- TCI $42.84
- LYEL N/A
- Revenue Growth
- TCI N/A
- LYEL N/A
- 52 Week Low
- TCI $25.50
- LYEL $0.39
- 52 Week High
- TCI $40.15
- LYEL $2.80
- Technical
- Relative Strength Index (RSI)
- TCI 73.06
- LYEL 51.63
- Support Level
- TCI $32.84
- LYEL $0.39
- Resistance Level
- TCI $40.15
- LYEL $0.43
- Average True Range (ATR)
- TCI 1.52
- LYEL 0.03
- MACD
- TCI 0.46
- LYEL 0.00
- Stochastic Oscillator
- TCI 88.78
- LYEL 83.39
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.